114 related articles for article (PubMed ID: 29172705)
21. Basement membrane components in mammary tumours of the dog and cat.
Benazzi C; Sarli G; Galeotti M; Marcato PS
J Comp Pathol; 1993 Oct; 109(3):241-52. PubMed ID: 8300912
[TBL] [Abstract][Full Text] [Related]
22. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop.
van Garderen E; de Wit M; Voorhout WF; Rutteman GR; Mol JA; Nederbragt H; Misdorp W
Am J Pathol; 1997 Mar; 150(3):1037-47. PubMed ID: 9060840
[TBL] [Abstract][Full Text] [Related]
23. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.
Ordás J; Millán Y; Dios R; Reymundo C; de Las Mulas JM
BMC Cancer; 2007 Sep; 7():179. PubMed ID: 17880730
[TBL] [Abstract][Full Text] [Related]
24. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.
Hahn P; Dentchev T; Qian Y; Rouault T; Harris ZL; Dunaief JL
Mol Vis; 2004 Aug; 10():598-607. PubMed ID: 15354085
[TBL] [Abstract][Full Text] [Related]
25. Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs.
Rutteman GR; Foekens JA; Portengen H; Vos JH; Blankenstein MA; Teske E; Cornelisse CJ; Misdorp W
Breast Cancer Res Treat; 1994; 30(2):139-46. PubMed ID: 7949212
[TBL] [Abstract][Full Text] [Related]
26. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.
Pizzamiglio S; De Bortoli M; Taverna E; Signore M; Veneroni S; Cho WC; Orlandi R; Verderio P; Bongarzone I
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216608
[TBL] [Abstract][Full Text] [Related]
27. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours.
Cherrington BD; Mohanan S; Diep AN; Fleiss R; Sudilovsky D; Anguish LJ; Coonrod SA; Wakshlag JJ
J Comp Pathol; 2012; 147(2-3):139-46. PubMed ID: 22520816
[TBL] [Abstract][Full Text] [Related]
29. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
30. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
31. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
32. Steroid receptors in mammary tumours of the cat.
Rutteman GR; Blankenstein MA; Minke J; Misdorp W
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():32-7. PubMed ID: 1801501
[TBL] [Abstract][Full Text] [Related]
33. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
34. A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.
Harman RM; Curtis TM; Argyle DJ; Coonrod SA; Van de Walle GR
J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):51-66. PubMed ID: 27002722
[TBL] [Abstract][Full Text] [Related]
35. Expression of Stat3 in feline mammary gland tumours and its relation to histological grade.
Petterino C; Ratto A; Arcicasa E; Podestà G; Drigo M; Pellegrino C
Vet Res Commun; 2006 Aug; 30(6):599-611. PubMed ID: 16838202
[TBL] [Abstract][Full Text] [Related]
36. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium.
Espinosa Los de Monteros A; Millán MY; Ordás J; Carrasco L; Reymundo C; Martín Las de Mulas J
Vet Pathol; 2002 Mar; 39(2):247-56. PubMed ID: 12009063
[TBL] [Abstract][Full Text] [Related]
37. Comparative pathology of mammary gland cancers in domestic and wild animals.
Munson L; Moresco A
Breast Dis; 2007; 28():7-21. PubMed ID: 18057539
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.
Jamnongkan W; Thanan R; Techasen A; Namwat N; Loilome W; Intarawichian P; Titapun A; Yongvanit P
Tumour Biol; 2017 Jul; 39(7):1010428317717655. PubMed ID: 28671021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
